Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
146.27 Up 1.71(1.18%) Jul 31, 4:00PM EDT
|After Hours : 146.27 0.00 (0.00%) Jul 31, 4:22PM EDT
Add to Portfolio
Prev Close:144.56
Open:145.44
Bid:118.25 x 1000
Ask:240.00 x 100
1y Target Est:149.53
Beta:1.09
Next Earnings Date: 3-Aug-15BMRN Earnings announcement
Day's Range:144.02 - 148.10
52wk Range:61.64 - 151.75
Volume:1,120,575
Avg Vol (3m):1,310,440
Market Cap:23.45B
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNUp 1.18%23.45B
FOLDUp 4.88%1.99B
SHPGUp 1.63%52.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.13
Quarterly EPS Est (Jun-15) :-0.53
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-2.71

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback